CIK 0001826667 · Non-accelerated filer<br>Smaller reporting company
TriSalus Life Sciences, Inc.
Sign in to watch- Ticker
- TLSI
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853009869
- Phone
- 415 336 8917
- Business address
- 6272 WEST 91ST AVENUE, WESTMINSTER, CO, 80031
- Former names
- MedTech Acquisition Corp, MedTech Acquisition Corporation
Securities
- TLSI Common Stock Nasdaq
- TLSIW Warrant Nasdaq
- 4 Grant or award Director acquired 51,266 shares (grant or award)
- 4 Grant or award Director acquired 52,754 shares (grant or award)
- 4 Grant or award Director acquired 43,590 shares (grant or award)
- 4 Conversion 10% owner acquired 759,000 shares (conversion)
- 4 Conversion Director acquired 330,000 shares (conversion)
- 4 Open-market sale Chief of Clinical Operations sold 3,207 shares at an average $4.11 ($13,171)
- 4 Open-market sale Chief of Research sold 3,184 shares at an average $4.11 ($13,085)
- 4 Open-market sale Chief Commercial Officer sold 3,457 shares at an average $4.11 ($14,210)
- 4 Open-market sale Chief Regulatory Officer sold 3,530 shares at an average $4.11 ($14,509)
- 4 Open-market sale CEO and President sold 20,302 shares at an average $3.91 ($79,383)
- 4 Open-market buy Chief Financial Officer bought 3,657 shares at $4.10 ($14,994)
- 4 Open-market buy Director bought 9,756 shares at $4.10 ($40,000)
- 4 Open-market buy Director bought 30,487 shares at $4.10 ($124,997)
- 4 Open-market buy CEO and President bought 30,487 shares at $4.10 ($124,997)
- 4 Open-market buy Director bought 361,098 shares at $4.10 ($1,480,502)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief of Research acquired 40,000 shares (grant or award)
- 4 Grant or award Chief of Clinical Operations acquired 50,000 shares (grant or award)
- 4 Grant or award CEO and President acquired 550,000 shares (grant or award)
Page 2 of 9 · 163 filings